Rapid Recovery of XRP Imperiled as Surprising 785,700% Hourly Liquidation Discrepancy Forces Long-Term Investors to Reconsider
In the ever-evolving world of cryptocurrency, XRP finds itself in a challenging position. The asset, XRP, has failed to soar in price as anticipated by investors, with its trading price currently at $2.82 β a 1.14% decline in the last 24 hours.
This volatility has taken a toll on both long and short position traders. Long position traders have suffered losses of $202,180 within the last 60 minutes, while short position traders have experienced a loss of $25.73 due to liquidation triggered by XRP's price fluctuations.
The Bollinger Bands indicator is flashing warnings, suggesting a potential breakout might not occur, further adding to the uncertainty surrounding XRP.
The asset's woes are exacerbated by the rise in Bitcoin dominance, which has worsened the threat to XRP's rebound move as investor interest shifts from altcoins.
Despite these challenges, many investors continue to believe that an XRP Exchange-Traded Fund (ETF) will be approved in 2025. However, the Securities and Exchange Commission (SEC) has yet to announce a decision on the approval of pending XRP ETF applications. The decision, initially scheduled for November 2025, has been postponed by the SEC.
Nate Geraci of the ETF Store maintains that an approval for an XRP ETF is inevitable, even as the SEC decision day approaches. This optimism, however, is countered by the deep red zone XRP's volume finds itself in, with a 25.02% decrease at $4.53 billion.
The XRP price chart shows that there are only two scenarios left. Despite reaching an intraday peak of $2.88, XRP could not sustain the climb due to low trading volume. Furthermore, XRP has slipped below its seven-day exponential moving average (EMA) of $2.85, increasing selling pressure and fluctuations.
In the last hour, XRP registered a 785,700% liquidation imbalance, further highlighting the asset's volatility. As the cryptocurrency market continues to evolve, the fate of XRP remains uncertain, with the SEC's decision on the pending ETF applications being a key factor in its potential rebound.
Read also:
- Peptide YY (PYY): Exploring its Role in Appetite Suppression, Intestinal Health, and Cognitive Links
- Toddler Health: Rotavirus Signs, Origins, and Potential Complications
- Digestive issues and heart discomfort: Root causes and associated health conditions
- House Infernos: Deadly Hazards Surpassing the Flames